Immunohistochemical Expression of p53, MDM2, and p21Wafi Oncoproteins in Endometriomas But Not Adenomyosis
article
OA: closed
CC0
⤵ 6 in-corpus citations
AI-generated summary
This study investigated the expression of p53, MDM2, and p21Waf1 oncoproteins in endometriomas and adenomyosis, finding differential expression patterns between the two conditions.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Objectivep53, MDM2, and p21Waf1 are oncoproteins that regulate the cell cycle. The purpose of this study was to examine the distribution of p53, MDM2, and p21Waf1 oncoprotein expression in endometriomas and in adenomyosis.MethodsTissue samples from 25 women with pathologically confirmed endometriomas and 31 women with pathologically confirmed adenomyosis were analyzed. Expression of p53, MDM2, and p21Waf1 oncoproteins was assessed by immunohistochemical nuclear staining.Resultsp53, MDM2, and p21Waf1 expression were detected in 20%, 60%, and 80% of endometrioma tissue samples, respectively. All endometrioma tissue samples expressing p53 also tested positive for both MDM2 and p21Waf1. MDM2 expression was significantly higher in the proliferative than in the secretory phase of the cycle. In contrast, all 31 adenomyosis tissue samples were negative for p53, MDM2, and p21Waf1 expression.ConclusionThe expression of p53, MDM2, and p21Waf1 suggests a role for these oncoproteins in the regulation of endometrioma cell growth, but not in adenomyosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (28)
- Adenomyosis: A clinical and pathologic appraisal via openalex
- Altered expression of interleukin-18 in the peritoneal fluid of women with endometriosis via openalex
- Apoptosis and the Pathogenesis of Endometriosis via openalex
- Apoptosis in human endometrium and endometriosis via openalex
- Cell Proliferation and apoptosis: Detection of apoptosis in human endometriotic tissues via openalex
- P53 Expression in Adenomyosis in Endometrial Carcinoma Patients via openalex
- Pathogenesis of endometriosis via openalex
- Pathogenesis of Endometriosis via openalex
- Pathogenesis of Endometriosis via openalex
- Somatic DNA alterations in endometriosis: high frequency of chromosome 17 and p53 loss in late-stage endometriosis via openalex
- W129012576 via openalex
- W2096977029 via openalex
- W2135535670 via openalex
- W2170494099 via openalex
- W2223163871 via openalex
- W2285972463 via openalex
- W2397204252 via openalex
- W2477008945 via openalex
- W2092675732 via openalex
- W1965531638 via openalex
- W2008301561 via openalex
- W2015519364 via openalex
- W2028712686 via openalex
- W2042782349 via openalex
- W2048961928 via openalex
- W2072711233 via openalex
- W2082979850 via openalex
- W2086708203 via openalex
Cited by (6)
- Peritoneal autoantibody landscape in endometriosis 2022
- Endometriosis Stem Cells as a Possible Main Target for Carcinogenesis of Endometriosis-Associated Ovarian Cancer (EAOC) 2022
- Exosomal lncRNA CHL1-AS1 Derived from Peritoneal Macrophages Promotes the Progression of Endometriosis via the miR-610/MDM2 Axis 2021
- Cancer driver mutations in endometriosis: Variations on the major theme of fibrogenesis 2018
- The TP53 16-bp Duplication Polymorphism Is Enriched in Endometriosis Patients 2012
- The role of iron in the pathogenesis of endometriosis 2009
Source provenance
- europepmc
- last seen: 2026-08-06T06:07:45.168820+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:15:41.664291+00:00
License: CC0
· commercial use OK